A protective role of early collateral blood flow in patients with ST-segment elevation myocardial infarction

Eun Kyoung Kim1, Jin-Ho Choi1, Young Bin Song1

  • 1Division of Cardiology, Cardiovascular Imaging Center, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

American Heart Journal
|December 25, 2015
PubMed

Insights

Good collateral blood flow in ST-segment elevation myocardial infarction (STEMI) patients significantly reduces infarct size and improves myocardial salvage. This finding highlights the protective role of collateral circulation in STEMI outcomes.

Area of Science:

  • Cardiology
  • Cardiovascular Research
  • Interventional Cardiology

Background:

  • The role of collateral circulation in ST-segment elevation myocardial infarction (STEMI) remains debated.
  • Understanding collateral flow's impact on infarct size and myocardial salvage is crucial for STEMI management.

Purpose of the Study:

  • To investigate the impact of collateral circulation on myocardial salvage and infarct size in STEMI patients.
  • To assess the association between collateral blood flow and infarct size in STEMI.

Main Methods:

  • Coronary angiography assessed initial collateral flow in 306 STEMI patients.
  • Cardiac magnetic resonance imaging measured infarct size and myocardial salvage within one week post-revascularization.

Main Results:

  • Good collaterals (Rentrop grade ≥ 2) were present in 22% of patients with preprocedural TIMI flow 0/1.
  • Patients with good collaterals had significantly smaller infarct size (17.1% vs 21.8%) and area at risk (33.8% vs 38.8%).
  • Good collateralization was associated with improved myocardial salvage index (50.9% vs 43.8%) and was an independent predictor of smaller infarct size.

Conclusions:

  • Well-developed collateral circulation in STEMI patients is independently associated with reduced infarct burden.
  • Effective collateralization improves myocardial salvage, potentially explaining lower mortality and morbidity in these patients.
  • These findings underscore the importance of assessing and potentially enhancing collateral flow in STEMI treatment strategies.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.6K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
446
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
421
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
709
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
10.7K